ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Erbitux 500 mg/100 ml, Infusionslösung - 100 ml
56072002 Merck (Schweiz) AG
Erbitux 500 mg/100 ml, Infusionslösung01.12.2003
  15.09.2014
(L01FE01)01.10.2007
WHO-DDD 
07.16.10.100 ml
07.16.10. 
A  
Yes 
IP 
937.18Yes
    
10 %1090.40
  
7680560720025Biotechnologika
6185153 
Composition
cetuximabum 500 mg, natrii chloridum, glycinum, polysorbatum 80, acidum citricum monohydricum, natrii hydroxidi solutio 1 mol/L, aqua ad iniectabile q.s. ad solutionem pro 100 ml natrium 288 mg.
Packungsbestandteile
Infusion solution 
  
 
Active AgentDose
Cetuximab500mg / 100ml
BAG: Active AgentDose
Cetuximab500 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Glycin 
Mol/l 
Sodium Chloride 
Natrii Hydroxidi Solutio1
Polysorbatum 80 
 
Source
Data was imported : 14.04.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home